Promising prostate cancer research
A breakthrough in prostate cancer treatment has the potential to be practice-changing.
Without doubt, one of the studies that generated most interest at the recent 2014 annual scientific meeting of the American Society of Clinical Oncology in Chicago was one led, and presented, by Dr Christopher Sweeney, an Australian-trained medical oncologist based at Dana-Farber Cancer Institute in Boston, MA.
Prevalence of prostate cancer
Prostate cancer is very common, with more than 18,500 diagnoses and 3400 deaths in Australia in 2012.1
Most patients are diagnosed in early-stage disease, curable with surgery or radiation, and with some early-stage cases growing so slowly, these may not need immediate treatment, nor any treatment at all.
In a small percentage of cases, the disease spreads to distant sites, most commonly regional lymph nodes and bone, and